← Leaderboards
Servio Heybert Ramirez
Temple Univ Of The Commonwealth
$5,873,481
Attributed
$9,413,267
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,413,267 · 5
By mechanism
R01$7,534,195 · 3
R61$1,117,046 · 1
P30$762,026 · 1
Top collaborators
- Raghava Potula6 shared
- Yuri Persidsky5 shared
- Allison Michelle Andrews3 shared
- Pooja Jain3 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Scott M Rawls$11,077,907
- Raghava Potula$4,276,324
- Yuri Persidsky$27,976,914
- Prasun K Datta$5,035,142
- Allison Michelle Andrews$4,229,979
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainCellsBlood - Brain Barrier AnatomyProteinsVirus ReplicationHiv InfectionsIn VivoInnovationChronicImmuneTight JunctionsFunctional DisorderEndotheliumAntiretroviral TherapyComplexNeuroinflammationLaboratoriesIn VitroMouse ModelAffectNeurovascular UnitKineticsHumanized MouseCytokine
Grant awards (23)
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$571,118
R01 · FY2025 · DA
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse$544,545
R61 · FY2025 · DA
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$604,910
R01 · FY2024 · DA
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$604,910
R01 · FY2023 · DA · contact PI
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse$572,500
R61 · FY2023 · DA
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse$1
R61 · FY2023 · DA
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$611,409
R01 · FY2022 · DA · contact PI
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$453,156
R01 · FY2022 · DA · contact PI
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$599,712
R01 · FY2021 · DA · contact PI
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2021 · DA · contact PI
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2020 · DA · contact PI
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2019 · DA · contact PI
Cell and Immunology Core$190,726
P30 · FY2019 · DA · contact PI
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$8,467
R01 · FY2019 · DA · contact PI
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2018 · DA · contact PI
Cell and Immunology Core$190,726
P30 · FY2018 · DA · contact PI
Novel serological biomarkers for BBB dysfunction during HIV-1 infection$390,000
R01 · FY2017 · NS · contact PI
Cell and Immunology Core$191,753
P30 · FY2017 · DA · contact PI
Novel serological biomarkers for BBB dysfunction during HIV-1 infection$390,000
R01 · FY2016 · NS · contact PI
Cell and Immunology Core$188,821
P30 · FY2016 · DA · contact PI
Novel serological biomarkers for BBB dysfunction during HIV-1 infection$390,000
R01 · FY2015 · NS · contact PI
Novel serological biomarkers for BBB dysfunction during HIV-1 infection$386,100
R01 · FY2014 · NS · contact PI
Novel serological biomarkers for BBB dysfunction during HIV-1 infection$387,917
R01 · FY2013 · NS · contact PI